DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Peri-implantitis Market

Global Peri-implantitis Market Opportunities and Forecast 2020-2027

  • DLR2663
  • 17 July, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Peri-implantitis Market, By Treatment (Surgical [Bone Regeneration, Open Flap Debridement, Implantoplasty], Non-surgical [Mechanical Debridement, Laser Debridement, Antibiotics, Others]) and opportunities and forecast 2020-2027

Peri-implantitis Market Overview

Peri-implantitis is a site-specific infectious disease that causes an inflammatory process in soft tissues, and bone loss around an osseointegrated implant in function. Treatment will differ depending upon whether it is a case of peri-implant mucositis or peri-implantitis.

The global Peri-implantitis market is expected to enlarge at a considerable rate in the forecast period. Important factors such as the increasing number of dental procedures, the rising number of oral diseases, and the growth of the elderly population with tooth loss have boosted the growth of the global peri-implantitis market. As well, dental implants have become recognized therapy in dentistry essential to replace missing teeth in different clinical situations. The success rate of dental implants is reported to be around 82.9% after 16 years of follow-up. However, 10%–50% of the dental implants exhibited signs of peri-implantitis after 10 years. In addition to this, According to NCBI, in the U.S. from 1999 to 2017, per year 14.0% increase in implant prevalence was recorded. Annually there are about 2,60,000 implants placed in the U.K., which indicates the growing demand for dental implants.

Additionally, the arrival of technological advancement relating to the efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are expected to fuel the market’s growth in the coming years.

On the downside, the high cost of dental procedures and lack of awareness are factors that hamper the growth of the peri-implantitis market in developing countries.

Covid-19 Impact on Peri-implantitis Market:

In addition, the current Peri-implantitis Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Peri-implantitis Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Peri-implantitis Market Segment Overview

Based on treatment, the surgical treatment segment is expected to increase at a high growth rate during the forecast period, as it is the most preferred option for the treatment of peri-implantitis. Additionally, the Laser debridement non-surgical technique is projected to witness the highest growth over the forecast period as it has improved clinical outcomes is efficient due to selective calculus removal.

Peri-implantitis Market, By Treatment
  • Surgical
    • Bone Regeneration
    • Open Flap Debridement
    • Implantoplasty
  • Non-surgical
    • Mechanical Debridement
    • Laser Debridement
    • Antibiotics
    • Others
Peri-implantitis Market Regional Overview

In terms of region, Europe is expected to be a dominant peri-implantitis market during the forecast period, followed by North America. Important factors such as increasing incidences of peri-implantitis, rising old age population, the surge in the number of dental issues and oral diseases, well-established health care infrastructure, and favorable reimbursement policies are driving the growth of the market in Europe. Similarly, the Asia Pacific is expected to register the fastest growth during the forecast period. Countries such as India and China contain large populations, favorable government initiatives, and the availability of developed health care facilities. This key fact majorly contributes to the market’s development in this region.

Peri-implantitis Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Peri-implantitis Market, Key Players

·       Geistlich Pharma Inc.
·       Aetna Inc.
·       Dawood & Tanner
·       Neoss
·       Pfizer Inc.
·       Cadila Pharmaceuticals
·       R.N. Laboratories Pvt. Ltd.
·       Basic Pharma Life Science Pvt. Ltd.
·       Prachi Pharmaceuticals Private Limited.
·       Healthy Life Pharma

Peri-implantitis Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Peri-implantitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Treatment
        • 5.2.1. Surgical
          • 5.2.1.1. Bone Regeneration
          • 5.2.1.2. Open Flap Debridement
          • 5.2.1.3. Implantoplasty
        • 5.2.2. Non-surgical
          • 5.2.2.1. Mechanical Debridement
          • 5.2.2.2. Laser Debridement
          • 5.2.2.3. Antibiotics
          • 5.2.2.4. Others
    • 5.3. Market Analysis, Insights and Forecast – By Region
      • 5.3.1. North America
      • 5.3.2. Europe
      • 5.3.3. Asia Pacific
      • 5.3.4. Latin America, Middle East and Africa
    • 6. North America Peri-implantitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Treatment
        • 6.2.1. Surgical
          • 6.2.1.1. Bone Regeneration
          • 6.2.1.2. Open Flap Debridement
          • 6.2.1.3. Implantoplasty
        • 6.2.2. Non-surgical
          • 6.2.2.1. Mechanical Debridement
          • 6.2.2.2. Laser Debridement
          • 6.2.2.3. Antibiotics
          • 6.2.2.4. Others
    • 6.3. Market Analysis, Insights and Forecast – By Country
      • 6.3.1. U.S.
      • 6.3.2. Canada
    • 7. Europe Peri-implantitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Treatment
        • 7.2.1. Surgical
          • 7.2.1.1. Bone Regeneration
          • 7.2.1.2. Open Flap Debridement
          • 7.2.1.3. Implantoplasty
        • 7.2.2. Non-surgical
          • 7.2.2.1. Mechanical Debridement
          • 7.2.2.2. Laser Debridement
          • 7.2.2.3. Antibiotics
          • 7.2.2.4. Others
    • 7.3. Market Analysis, Insights and Forecast – By Country
      • 7.3.1. UK
      • 7.3.2. Germany
      • 7.3.3. France
      • 7.3.4. Italy
      • 7.3.5. Spain
      • 7.3.6. Russia
      • 7.3.7. Rest of Europe
    • 8. Asia Pacific Peri-implantitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Treatment
        • 8.2.1. Surgical
          • 8.2.1.1. Bone Regeneration
          • 8.2.1.2. Open Flap Debridement
          • 8.2.1.3. Implantoplasty
        • 8.2.2. Non-surgical
          • 8.2.2.1. Mechanical Debridement
          • 8.2.2.2. Laser Debridement
          • 8.2.2.3. Antibiotics
          • 8.2.2.4. Others
    • 8.3. Market Analysis, Insights and Forecast – By Country
      • 8.3.1. China
      • 8.3.2. India
      • 8.3.3. Japan
      • 8.3.4. Australia
      • 8.3.5. South East Asia
      • 8.3.6. Rest of Asia Pacific
    • 9. Latin America, Middle East and Africa Peri-implantitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Treatment
        • 9.2.1. Surgical
          • 9.2.1.1. Bone Regeneration
          • 9.2.1.2. Open Flap Debridement
          • 9.2.1.3. Implantoplasty
        • 9.2.2. Non-surgical
          • 9.2.2.1. Mechanical Debridement
          • 9.2.2.2. Laser Debridement
          • 9.2.2.3. Antibiotics
          • 9.2.2.4. Others
    • 9.3. Market Analysis, Insights and Forecast – By Country
      • 9.3.1. Brazil
      • 9.3.2. Saudi Arabia
      • 9.3.3. UAE
      • 9.3.4. Rest of LAMEA
    • 10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Geistlich Pharma Inc.
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Aetna Inc.
      • 10.6. Dawood & Tanner
      • 10.7. Neoss
      • 10.8. Pfizer Inc.
      • 10.9. Cadila Pharmaceuticals
      • 10.10. R.N. Laboratories Pvt. Ltd.
      • 10.11. Basic Pharma Life Science Pvt. Ltd.
      • 10.12. Prachi Pharmaceuticals Private Limited.

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934